Mutations in PTCH or SMO are also prevalent in basal cell carcinomas, medulloblastomas, and cancers of the esophagus and bladder (102), and sustained and activated Hh-Gli signaling has led to the development of medulloblastomas in PTCH heterozygous mice (106). Here, SMO is linked to basal cell carcinoma.